HR or Marketing? Claim Your Free Employer Account
Jean-Paul Kress M.D. ā Executive VP, President of International, Head of Global Therapeutic Operations at Biogen
Executive Bio
Dr. Jean-Paul Kress, M.D. has been an Executive Vice President, President of International and Head of Global Therapeutic Operations at Biogen Inc. since June 19, 2017. Dr. Kress have direct responsibility for worldwide commercial operations outside the U.S. and also oversee the Rare and Specialty Disease Asset teams. Previously, Dr. Kress served as Head of North America, Sanofi Genzyme Specialty Care Business Unit (Multiple Sclerosis, Oncology & Immunology). Dr. Kress served as President of Sanofi Pasteur MSD ApS. He served as President of Sanofi Pasteur MSD Limited from July 2011 to September 2015 and also served as its Chief Executive Officer until 2015. During his tenure with Sanofi Pasteur MSD, a joint venture between Sanofi Pasteur and Merck & Co (known as MSD outside the US and Canada), he embarked on a series of changes to reshape MSD to better meet the challenges of the rapidly changing vaccine industry and to drive the launches of a number of innovative new products. His ability to mobilize MSD to focus on the most critical priorities resulted in a turnaround of the business and provided a firm foundation for sustainable growth. A strong advocate for the socio-economic value of vaccination, Dr. Kress was actively involved in the development of health policy across the EU with a focus on disease prevention. Prior to his work at Sanofi Pasteur MSD, he served as Vice President and General Manager in France for Gilead, a major US-based biopharmaceutical company specialized in therapeutics for life-threatening diseases such as HIV. He joined Gilead in California in 2006 as Vice President, US Sales and Marketing. He served as a Director of Sarepta Therapeutics, Inc. from September 30, 2015 to June 6, 2017. He serves as a Director of CNE (the ENS Alumni association). Dr. Kress holds an MD from Facult?? Necker-Enfants Malades in Paris, France and is an alumnus of the prestigious Ecole Normale Sup??rieure in Paris, France. Dr. Kress holds graduate and post-graduate degrees in biochemistry and molecular and cellular pharmacology from Ecole normale superieure, Paris.
Executive Team Culture Ratings from Biogen Employees
TOP
40%
Biogen's Executive Team scores in the Top 40%
of similar sized companies on Comparably
of similar sized companies on Comparably
Biogen's Executive Team at a Glance
Based on 94 ratings, Biogen's employees are satisfied with their Executive Team and give them a āB-ā or 68/100. On average, Men provided higher ratings for their Executive Team compared to Women. Also, the HR department thinks more highly of the Executive Team relative to the Customer Support department.
Biogen's Executive Team ranks in the Top 50% of other companies in Boston and Top 40% of other companies on Comparably that also have 5,001-10,000 Employees.
×